Literature DB >> 17980519

A new PCR followed by MboI digestion for the detection of all variants of the Clostridium perfringens cpb2 gene.

Alphons J A M van Asten1, Janneke G Allaart, Arjan D Meeles, Peggy W J M Gloudemans, Dirk J Houwers, Andrea Gröne.   

Abstract

Clostridium perfringens which is a causative agent of several diseases in animals and humans is capable of producing a variety of toxins. Isolates are typed into five types on the basis of the presence of one or more of the four major toxins genes, i.e. cpa, cpb, etx, and iap. A decade ago another toxin termed beta2 (beta2) and its gene (cpb2) were identified. Two alleles of cpb2 are known and a possible link between differences in gene expression and allelic variation has been reported. A correlation between the level of expression and the origin of the isolates has also been suggested. The demonstration and typing of the cpb2 gene in the genome of isolates can be seen as a vital part of research on the role of the beta2 toxin in the pathogenesis of disease. This study describes a PCR with a single primer set which in contrast to published primer sets recognizes both alleles. Subsequent restriction enzyme analysis of the PCR product enables typing of the alleles. Applying this protocol on a total of 102 isolates, a sub-variant was found which occurred only in C. perfringens isolates from pigs and appeared to be the predominant variant found in C. perfringens isolates from this species.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17980519     DOI: 10.1016/j.vetmic.2007.08.035

Source DB:  PubMed          Journal:  Vet Microbiol        ISSN: 0378-1135            Impact factor:   3.293


  1 in total

1.  Necrotic enteritis-derived Clostridium perfringens strain with three closely related independently conjugative toxin and antibiotic resistance plasmids.

Authors:  Trudi L Bannam; Xu-Xia Yan; Paul F Harrison; Torsten Seemann; Anthony L Keyburn; Christopher Stubenrauch; Lakmini H Weeramantri; Jackie K Cheung; Bruce A McClane; John D Boyce; Robert J Moore; Julian I Rood
Journal:  MBio       Date:  2011-09-27       Impact factor: 7.867

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.